VAN HERK INVESTMENTS B.V.

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0001633120
All SEC filings
View on sec.gov
Issuer % of Class Filed
ProQR Therapeutics N.V. 13D/A Amendment 7
PRQR · N71542109
10.9% 7/29/2026
Event 7/27/2026
ProQR Therapeutics N.V. 13D/A Amendment 6
PRQR · N71542109
10.9% 6/30/2026
Event 6/26/2026
ProQR Therapeutics N.V. 13D/A Amendment 5
PRQR · N71542109
14.6% 6/3/2026
Event 6/2/2026
ProQR Therapeutics N.V. 13D/A Amendment 4
PRQR · N71542109
14.6% 2/6/2026
Event 2/5/2026
ProQR Therapeutics N.V. 13D/A Amendment 3
PRQR · N71542109
13.6% 9/30/2025
Event 9/29/2025
ProQR Therapeutics N.V. 13D/A Amendment 2
PRQR · N71542109
12.6% 9/4/2025
Event 9/3/2025
ProQR Therapeutics N.V. 13D/A Amendment 1
PRQR · N71542109
11.6% 8/20/2025
Event 8/19/2025
ProQR Therapeutics N.V. 13D
PRQR · N71542109
10.9% 5/28/2025
Event 5/23/2025
ProQR Therapeutics N.V. 13G/A Amendment 3
PRQR · N71542109
10.9% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.